Generic Name: Omalizumab
Brand Name: Xolair
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Therapeutic Area: Chronic idiopathic urticaria
Indications: Urticaria, chronic idiopathic
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: May 7, 2015
Recommendation Type: List with clinical criteria and/or conditions